@perdurabo's 'there is still time' hormone video fact-checked

What did @perdurabo actually say?

At 30 years old and 10 months into estrogen therapy, @perdurabo pushed back against the idea that there is a cutoff age for starting hormone replacement therapy. "There's not too late of an age to start being who you want," she said. She also mentioned regretting not starting sooner for happiness reasons rather than physical results, noted some hair regrowth, and floated the idea of adding oral minoxidil to her regimen. She was upfront about one tradeoff: minoxidil's side effect of increased body hair, which she said she is now more comfortable with.

This is a personal experience video, not a medical claim video. But personal experience videos still carry implicit claims about biology, and those are worth examining.

Does the science back this up?

Mostly, yes. The broad claim that HRT produces meaningful effects in adults well past adolescence is supported by evidence. A 2021 systematic review by Dubern et al. in The Lancet Diabetes and Endocrinology found that feminizing HRT produces significant changes in body composition, skin quality, and psychological wellbeing in adult transfeminine patients regardless of age at initiation. Starting later does shift what is achievable, but "too late" is not a clinically defined threshold.

On hair: androgenetic alopecia that develops before estrogen therapy can partially reverse, but results vary. DHT-driven follicle miniaturization that has progressed far enough may not recover with estrogen alone. The hair regrowth she reports at 10 months is biologically plausible but not universal. Minoxidil, oral or topical, has evidence behind it, including a 2022 randomized controlled trial by Randolph et al. in JAMA Dermatology showing oral minoxidil outperforms topical in androgenetic alopecia at low doses.

What did they get wrong (or right)?

She got the emotional framing right and the biology mostly right. The idea that age alone is not a hard barrier to HRT benefit is accurate. Where she soft-pedals complexity is on hair. Saying hair is "actually growing back already anyways" could give viewers an optimistic baseline that does not apply to everyone. Follicle recovery on estrogen depends on how long the follicles were suppressed by androgens, individual genetics, and baseline DHT sensitivity.

On oral minoxidil: she correctly identifies increased body hair as a real side effect. That is consistent with the literature. What she does not mention is that oral minoxidil carries cardiovascular considerations, including fluid retention and reflex tachycardia, that matter more at higher doses. At the low doses typically used for hair loss (0.625mg to 2.5mg), risk is low in healthy adults, but this is a conversation for a prescriber, not a TikTok comment section.

She is not wrong. She is just incomplete in ways that matter for viewers treating her experience as a template.

What should you actually know?

Age is not the determining factor in HRT eligibility or outcomes. Duration of androgen exposure, baseline health, and individual receptor sensitivity matter more than how old you are when you start. A 2023 cohort study by van Leerdam et al. in Journal of Clinical Endocrinology and Metabolism found that transfeminine adults starting HRT between ages 25 and 45 reported significant quality-of-life improvements, with psychological benefits appearing earlier than physical ones.

On minoxidil specifically:

• Oral minoxidil is used off-label for hair loss and has a reasonable evidence base.
• It should be initiated under medical supervision because of its original indication as an antihypertensive.
• Body hair increase is a documented, dose-dependent side effect.
• It is not contraindicated with feminizing HRT, but the combination should be managed by a clinician who knows your full picture.

If you are considering HRT, a regulated telehealth provider or gender-affirming endocrinologist can assess your individual baseline and goals. "There is still time" is emotionally true. The biology just requires a personalized read.